Jade Biosciences, Inc.
NASDAQ:JBIOBiotechnology
Healthcare
$15.49 -1.25%
-$0.21 today
- Market cap
- $1.07B
- Beta
- 1.45
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$2.24
52W Low $6.67High $28.00
Volume 0.79M
Average 0.83M
Balance Sheet
Inspect the capital base behind the business.
Assets
$349.78M
FY 2025 · Annual
+335.4% YoYLiabilities
$17.26M
FY 2025 · Annual
+342.9% YoYEquity
$332.52M
FY 2025 · Annual
+335.0% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 54.2M | 22.4M | 23.49M | 33.75M | 88.44M |
| Short-term Investments | 113.18M | 106.82M | 98.95M | 44.87M | 247.72M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 240K | 295K | 250K | 845K | 0 |
| Total Current Assets | 174.33M | 131.5M | 124.23M | 80.12M | 336.16M |
| Property, Plant & Equipment (Net) | 728K | 1.25M | 902K | 215K | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 302K | 2.56M | 2.28M | 0 | 13.62M |
| Total Non-current Assets | 1.03M | 3.8M | 3.19M | 215K | 13.62M |
| Total Assets | 175.36M | 135.3M | 127.42M | 80.33M | 349.78M |
| Account Payables | 1.21M | 2.58M | 2.4M | 224K | 2.15M |
| Short-term Debt | 192K | 385K | 420K | 417K | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 360K | 3.13M | 10.45M | 319K | 3.32M |
| Total Current Liabilities | 2.55M | 7.78M | 17.64M | 3.83M | 16.54M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 13K | 71K | 70K | 70K | 0 |
| Total Non-current Liabilities | 395K | 776K | 325K | 70K | 724K |
| Total Liabilities | 2.95M | 8.56M | 17.96M | 3.9M | 17.26M |
| Common Stock | 2K | 2K | 3K | 3K | 5K |
| Retained Earnings | (36.39M) | (87.9M) | (163.42M) | (233.05M) | (174.39M) |
| Accumulated OCI | (59K) | (466K) | 237K | 105K | 129K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 172.42M | 126.74M | 109.46M | 76.43M | 332.52M |
| Total Debt | 574K | 1.09M | 675K | 417K | 724K |
| Net Debt | (53.62M) | (21.31M) | (22.82M) | (33.33M) | (87.71M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $55.1M |
| Short-term Investments | $256.2M |
| Other Current | $7.2M |
| Total Current Assets | $318.5M |
| PP&E (Net) | $847.0K |
| Other Non-current | $69.0K |
| Total Non-current Assets | $916.0K |
| Total Assets | $319.4M |
Analysis
Selected assets total $319.4M for Latest. The largest visible component is Short-term Investments at $256.2M, about 80.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Oct 28, 2026 | |
| SC 13G | SC 13G filing | Oct 27, 2026 | |
| 424B5 | 424B5 filing | Jun 3, 2026 |
How much cash does JBIO have?
Jade Biosciences, Inc. (JBIO) reported $88.44M in cash and equivalents in fiscal 2025.
How much debt does JBIO carry?
Jade Biosciences, Inc. (JBIO) reported $724,000.00 of total debt, with net debt of -$87.71M.
Continue the stock analysis
Jump to another research area for this company.